ACAndrea Cediel-Ulloa

Andrea Cediel-Ulloa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrea Cediel-Ulloa has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Linking nuclear receptor antagonism with neuronal morphology improves detection of developmental neurotoxicants

    by Andrea Cediel-Ulloa, Marie Guissard, Annie Eriksson, Saga Hörling, Anna Forsby, Joëlle Rüegg

    Brain development is highly dependent on hormonal signaling, hence developmental exposure to endocrine disrupting chemicals (EDCs) is of high concern. However, existing EDC hazard assessment methods lack the capacity to connect developmental neurotoxicity (DNT) to an endocrine mode of action, creating an urgent need for innovative tools addressing endocrine disruption (ED)-induced DNT. We have previously shown the applicability of the immortalized C17.2 murine neural progenitor cells for addressing ED-DNT. In this test sys-tem, the key neurodevelopmental processes (KNDPs) neurite outgrowth and branching were decreased by agonism of retinoic acid receptor (RAR), retinoic X receptor (RXR) and peroxisome proliferator-activated recep-tor (PPAR) β/δ. In the current study we further validate the use, and assess the added value, of the C17.2 test system for detection of ED-induced DNT by testing the effects of 17 chemicals on neuronal morphology and comparing the results to published DNT in vitro toxicity data. Out of the tested chemicals, endosulfan and cy-permethrin decreased neurite outgrowth and branching when tested alone. However, while permethrin, bi-sphenol F (BPF), benzyl butyl phthalate (BBzP) and its metabolite MBzP, perfluorooctanesulfonic acid (PFOS), and 3-phenoxybenzoic acid (3-PBA) did not independently reduce neurite outgrowth, they counteracted RAR, RXR or PPARβ/δ agonist-induced decreases, indicating antagonistic activity. Compared to neurite morphology-related endpoints in ToxCast, C17.2 cells identified more chemicals as active, with increased sensitivity to this endpoint category. These findings confirm that the C17.2 test system is a valuable in vitro model for detecting ED-induced DNT, and that receptor agonist co-treatment enables identification of additional DNT compounds. Plain language summaryChemicals in our environment can interfere with the body’s hormonal system and harm brain development, particularly in children. Identifying which chemicals pose this risk is challenging because current testing meth-ods are limited in their ability to connect hormone disruption to developmental brain damage. The current study demonstrated that a cell-based model, C17.2 cells, can reliably detect chemicals that disrupt hormonal path-ways linked to abnormal brain development. By observing the morphology of these cells, we can identify both chemicals that activate and those that block hormonal signals. The C17.2 model addresses a critical gap in current guidelines for assessing hormone-disrupting chemicals while reducing and replacing the need for ani-mal testing in line with the 3R principles, making it a valuable tool for improving chemical safety assessment and protecting public health.

  • Open Access

    Transcriptomic characterization of maturing neurons from human neural stem cells across developmental time points

    by Kimia Hosseini, Gaëtan Philippot, Sara B. Salomonsson, Andrea Cediel-Ulloa, Elnaz Gholizadeh, Robert Fredriksson


  • Open Access

    Assessing the Neurodevelopmental Impact of Fluoxetine, Citalopram, and Paroxetine on Neural Stem Cell-Derived Neurons

    by Kimia Hosseini, Andrea Cediel-Ulloa, Mohamed H. Al-Sabri, Anna Forsby, Robert Fredriksson

    Background/Objectives: Many pregnant women globally suffer from depression and are routinely prescribed selective serotonin reuptake inhibitors (SSRIs). These drugs function by blocking the re-uptake of serotonin by the serotonin transporter (SERT) into neurons, resulting in its accumulation in the presynaptic cleft. Despite a large amount of research suggesting a potential link to neurodevelopmental disorders in children whose mothers took these drugs during pregnancy, their possible adverse effects are still debated, and results are contradictory. On the other hand, there is an immediate need for improved cell-based models for developmental neurotoxicity studies (DNT) to minimize the use of animals in research. Methods: In this study, we aimed to assess the effects of clinically relevant concentrations of paroxetine (PAR), fluoxetine (FLX), and citalopram (CIT)—on maturing neurons derived from human neural stem cells using multiple endpoints. Results: Although none of the tested concentrations of FLX, CIT, or PAR significantly affected cell viability, FLX (10 µM) exhibited the highest reduction in viability compared to the other drugs. Regarding neurite outgrowth, CIT did not have a significant effect. However, FLX (10 µM) significantly reduced both mean neurite outgrowth and mean processes, PAR significantly reduced mean processes, and showed a trend of dysregulation of multiple genes associated with neuronal development at therapeutic-relevant serum concentrations. Conclusions: Transcriptomic data and uptake experiments found no SERT activity in the system, suggesting that the adverse effects of FLX and PAR are independent of SERT.


  • Open Access

    Characterization of the C17.2 cell line as testing system for endocrine disruption-induced developmental neurotoxicity

    by Andrea Cediel-Ulloa, Roseline Awoga, Arif Dönmez, Ximiao Yu, Anda Gliga, Kristina Attoff, Anna Forsby, Joëlle Rüegg

    Hormone signaling plays an essential role during fetal life and is vital for brain development. Endocrine-disrupting chemicals can interfere with the hormonal milieu during this critical time-period, disrupting key neurodevelopmental processes. Hence, there is a need for the development of assays that evaluate developmental neurotoxicity (DNT) induced by an endocrine mode of action. Herein, we evaluated the applicability of the neural progenitor C17. 2 cell-line, as an in vitro test system to aid in the detection of endocrine disruption (ED) induced DNT. For this, C17.2 cells were exposed during 10 days of differentiation to agonists and antagonists of the thyroid hormone (Thr), glucocorticoid (Gr), retinoic acid (Rar), retinoic x (Rxr), oxysterols (Lxr), estrogen (Er), androgen (Ar), and peroxisome proliferator activated delta (Pparβ/δ) receptors, as well as to the agonist of the vitamin D (Vdr) receptor. Upon exposure and differentiation, neuronal morphology (neurite outgrowth and branching), and the percentage of neurons in culture were assessed by immunofluorescence. For this, the cells were incubated with Hoechst (nuclear staining) and stained for βIII-tubulin (neuronal marker). The C17.2 cells were responsive to the Rar, Rxr and Pparβ/δ agonists which decreased neurite outgrowth and branching. Additionally, exposure to the Gr agonist increased the number of cells differentiating into neurons, while exposure to the Rxr agonist had the opposite effect. With this approach, we have identified that the C17.2 cells are responsive to Gr, Rar, Rxr, and Pparβ/δ agonists, hence contributing to the development of test systems for hazard assessment of ED-induced DNT. Plain language summaryEndocrine disrupting chemicals (EDCs) interfere with hormonal signaling. As hormones play a vital role for an organism’s development, EDC exposure is of high concern. In European regulations, the use of a chemical can be restricted if its toxicity is mediated by hormonal interference. A number of EDCs affect brain development. However, in animal tests, it is impossible to prove that a chemical induces developmental neurotoxicity (DNT) via endocrine disruption (ED). Furthermore, the regulatory DNT tests require large amounts of animals. Thus, there is an urgent need for in vitro test systems to identify ED-induced DNT. Herein we present the development of such a method based on the murine neural progenitor cell-line C17.2 with which neuronal differentiation processes can be mimicked. We show that differentiation of C17.2 cells are sensitive to retinoid, glucocorticoid, and peroxisome proliferator activated receptor signaling disruption, thus providing an alternative method for identifying ED-induced DNT.


  • Open Access

    Endocrine-Disrupting Chemicals and Hippocampal Development: The Role of Estrogen and Androgen Signaling

    by Diana-Ioana Lupu, Andrea Cediel Ulloa, Joëlle Rüegg

    Hormones are important regulators of key processes during fetal brain development. Thus, the developing brain is vulnerable to the action of chemicals that can interfere with endocrine signals. Epidemiological studies have pointed toward sexually dimorphic associations between neurodevelopmental outcomes, such as cognitive abilities, in children and prenatal exposure to endocrine-disrupting chemicals (EDCs). This points toward disruption of sex steroid signaling in the development of neural structures underlying cognitive functions, such as the hippocampus, an essential mediator of learning and memory processes. Indeed, during development, the hippocampus is subjected to the organizational effects of estrogens and androgens, which influence hippocampal cell proliferation, differentiation, dendritic growth, and synaptogenesis in the hippocampal fields of Cornu Ammonis and the dentate gyrus. These early organizational effects correlate with a sexual dimorphism in spatial cognition and are subject to exogenous chemical perturbations. This review summarizes the current knowledge about the organizational effects of estrogens and androgens on the developing hippocampus and the evidence for hippocampal-dependent learning and memory perturbations induced by developmental exposure to EDCs. We conclude that, while it is clear that sex hormone signaling plays a significant role during hippocampal development, a complete picture at the molecular and cellular levels would be needed to establish causative links between the endocrine modes of action exerted by EDCs and the adverse outcomes these chemicals can induce at the organism level.


  • Open Access

    Impact of endocrine disrupting chemicals on neurodevelopment: the need for better testing strategies for endocrine disruption-induced developmental neurotoxicity

    by Andrea Cediel-Ulloa, Diana Loana Lupu, Ylva Johansson, Maria Hinojosa, Fatih Özel, Joëlle Rüegg

    Brain development is highly dependent on hormonal regulation. Exposure to chemicals disrupting endocrine signaling has been associated with neurodevelopmental impairment. This raises concern about ...


  • Open Access

    Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants

    by Johannes Delp, Melina Funke, Franziska Rudolf, Andrea Cediel, Susanne Hougaard Bennekou, Wanda van der Stel, Giada Carta, Paul Jennings, Cosimo Toma, Iain Gardner, et al.

    Many neurotoxicants affect energy metabolism in man, but currently available test methods may still fail to predict mito- and neurotoxicity. We addressed this issue using LUHMES cells, i.e., human neuronal precursors that easily differentiate into mature neurons. Within the NeuriTox assay, they have been used to screen for neurotoxicants. Our new approach is based on culturing the cells in either glucose or galactose (Glc–Gal–NeuriTox) as the main carbohydrate source during toxicity testing. Using this Glc–Gal–NeuriTox assay, 52 mitochondrial and non-mitochondrial toxicants were tested. The panel of chemicals comprised 11 inhibitors of mitochondrial respiratory chain complex I (cI), 4 inhibitors of cII, 8 of cIII, and 2 of cIV; 8 toxicants were included as they are assumed to be mitochondrial uncouplers. In galactose, cells became more dependent on mitochondrial function, which made them 2–3 orders of magnitude more sensitive to various mitotoxicants. Moreover, galactose enhanced the specific neurotoxicity (destruction of neurites) compared to a general cytotoxicity (plasma membrane lysis) of the toxicants. The Glc–Gal–NeuriTox assay worked particularly well for inhibitors of cI and cIII, while the toxicity of uncouplers and non-mitochondrial toxicants did not differ significantly upon glucose ↔ galactose exchange. As a secondary assay, we developed a method to quantify the inhibition of all mitochondrial respiratory chain functions/complexes in LUHMES cells. The combination of the Glc–Gal–NeuriTox neurotoxicity screening assay with the mechanistic follow up of target site identification allowed both, a more sensitive detection of neurotoxicants and a sharper definition of the mode of action of mitochondrial toxicants.